These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8673724)
1. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor. Feng N; Schnyder B; Vonderschmitt DJ; Ryffel B; Lutz RA J Recept Signal Transduct Res; 1995; 15(7-8):931-49. PubMed ID: 8673724 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930 [TBL] [Abstract][Full Text] [Related]
3. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652 [TBL] [Abstract][Full Text] [Related]
4. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts. Lutz RA; Feng N; Moser R J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757 [TBL] [Abstract][Full Text] [Related]
5. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184 [TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain. Kuznetsov VA; Puri RK Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747 [TBL] [Abstract][Full Text] [Related]
7. A synthetic peptide corresponding to a critical intracellular signaling region of the human IL-4 receptor inhibits IL-4-induced proliferation. Izuhara K; Sakai M; Inaba R; Imamura T; Howard M; Harada N Cell Immunol; 1995 Jul; 163(2):254-9. PubMed ID: 7606796 [TBL] [Abstract][Full Text] [Related]
8. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868 [TBL] [Abstract][Full Text] [Related]
9. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells. Obiri NI; Puri RK Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528 [TBL] [Abstract][Full Text] [Related]
10. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. Murata T; Obiri NI; Debinski W; Puri RK Biochem Biophys Res Commun; 1997 Sep; 238(1):90-4. PubMed ID: 9299458 [TBL] [Abstract][Full Text] [Related]
12. The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. He YW; Malek TR J Immunol; 1995 Jul; 155(1):9-12. PubMed ID: 7602126 [TBL] [Abstract][Full Text] [Related]
13. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Kunikata T; Torigoe K; Ushio S; Okura T; Ushio C; Yamauchi H; Ikeda M; Ikegami H; Kurimoto M Cell Immunol; 1998 Nov; 189(2):135-43. PubMed ID: 9790727 [TBL] [Abstract][Full Text] [Related]
14. Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells. Foxwell BM; Woerly G; Ryffel B Eur J Immunol; 1989 Sep; 19(9):1637-41. PubMed ID: 2529125 [TBL] [Abstract][Full Text] [Related]
15. Chromosome mapping and expression of the human interleukin-13 receptor. Guo J; Apiou F; Mellerin MP; Lebeau B; Jacques Y; Minvielle S Genomics; 1997 May; 42(1):141-5. PubMed ID: 9177784 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein. Joshi BH; Leland P; Puri RK Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150 [TBL] [Abstract][Full Text] [Related]
17. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. Leland P; Obiri N; Aggarwal BB; Puri RK Oncol Res; 1995; 7(5):227-35. PubMed ID: 8534928 [TBL] [Abstract][Full Text] [Related]
18. Differential responses of human monocytes and macrophages to IL-4 and IL-13. Hart PH; Bonder CS; Balogh J; Dickensheets HL; Donnelly RP; Finlay-Jones JJ J Leukoc Biol; 1999 Oct; 66(4):575-8. PubMed ID: 10534111 [TBL] [Abstract][Full Text] [Related]
19. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974 [TBL] [Abstract][Full Text] [Related]
20. STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Wang IM; Lin H; Goldman SJ; Kobayashi M Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]